Jim Potter, executive director of the Coalition for Healthcare Communications, warns: "The courts view advertising as a form of commercial speech, and they've ruled in a series of cases dating back to the 1970s that banning advertising violates First Amendment protections of freedom of speech." He highlights the legal risks the administration may face if it attempts to impose a ban on pharmaceutical ads.
Weissman expresses concern over Kennedy's stance on health issues: "I think when Robert Kennedy talks about fighting corruption and Big Pharma monopolies, that is going to translate into reducing standards at FDA to enable the authorization and promotion of ineffective and dubious therapies, drugs, herbs, whatever," illuminating the potential implications of Kennedy’s policies.
Collection
[
|
...
]